Cullinan Therapeutics CGEM Income Statement (2020-2026)

NASDAQ CGEM
$15.23 +0.28 (+1.87%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Cullinan Therapeutics Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Cullinan Therapeutics reported net income of -$53.61M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
43.66M44.29M44.66M45.40M45.74M45.80M39.34M42.74M42.76M42.90M43.07M57.87M58.14M58.51M58.70M59.07M59.08M60.24M61.45M64.35M
Revenue & cost
Revenue
Operating items
Research & DevelopmentR&D
12.68M20.88M24.54M26.41M19.68M21.32M52.10M27.39M33.82M34.85M30.65M36.26M35.51M40.49M41.46M61.03M41.97M42.95M42.12M44.44M
Share-based Compensation (IS)
7.26M7.92M7.74M8.23M10.53M9.43M9.37M9.89M9.47M7.62M8.45M
Selling, General & AdministrativeSG&A
5.70M13.47M8.12M10.70M10.09M11.29M10.66M10.21M10.98M10.64M12.34M13.77M13.35M14.56M13.54M14.77M13.63M12.31M11.57M12.82M
Operating ExpensesOpex
18.38M34.35M32.66M37.11M29.77M32.61M62.76M37.60M44.80M45.48M42.99M50.03M48.85M55.05M55.00M75.80M55.59M55.26M53.70M57.25M
Operating IncomeOp. Inc
-18.38M-34.35M-32.66M239.68M-29.77M-32.61M-62.76M-37.60M-45.24M-45.48M-42.99M-50.03M-48.85M-55.05M-55.00M-75.80M-55.59M-55.26M-53.70M-57.25M
EBIT
-18.38M-34.35M-32.66M239.68M-29.77M-32.61M-62.76M-37.60M-45.24M-45.48M-42.99M-50.03M-48.85M-55.05M-55.00M-75.80M-55.59M-55.26M-53.70M-57.25M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
0.12M0.14M0.20M0.70M2.35M3.36M4.51M5.32M5.88M5.92M5.69M8.07M8.38M7.51M6.58M5.92M5.09M4.62M4.10M3.65M
Other Non Operating IncomeOther Non Op Inc.
-0.00M0.00M-0.24M0.30M0.11M0.07M0.18M-0.12M-0.04M-0.07M-0.09M0.01M-0.09M-0.18M-0.11M-0.07M-0.06M-0.10M
Net income details
EBT
-18.26M-34.21M-32.46M240.13M-27.41M-28.95M-58.14M-32.21M-39.18M-39.69M-37.30M-41.96M-40.47M-47.54M-48.42M-69.87M-50.50M-50.64M-49.60M-53.61M
Tax ProvisionsTaxes
-19.60M66.07M-2.52M-1.88M-14.12M
Profit After TaxPAT
-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M-37.30M-41.96M-40.47M-47.54M-48.42M-69.87M-50.50M-50.64M-49.60M-53.61M
Income from Non-Controlling InterestsInc. Minority
-0.91M-1.69M-0.79M-0.83M-0.09M-0.31M-0.18M-1.76M-0.19M
Income from Continuing OperationsIncome (Continuing)
-18.26M-34.21M-12.86M174.06M-24.89M-27.07M-58.14M-32.21M-39.18M-25.56M-37.30M-41.96M-40.47M-47.54M-48.42M-69.87M-50.50M-50.64M-49.60M-53.61M
Consolidated Net IncomeConsol Net Inc.
-18.26M-34.21M-12.89M174.06M-24.89M-27.09M-58.14M-32.21M-39.18M-25.56M-37.34M-42.03M-40.56M-47.65M-48.50M-70.06M-50.61M-50.71M-49.66M-53.70M
Income towards Parent CompanyParent Net Inc
-17.35M-32.51M-12.10M174.90M-24.80M-26.78M-57.96M-32.21M-39.18M-23.80M-37.15M-42.03M-40.56M-47.65M-48.50M-70.06M-50.61M-50.71M-49.66M-53.70M
Net Income towards Common StockholdersNet Income
-17.35M-32.51M-12.10M174.90M-24.80M-26.78M-57.96M-32.21M-39.18M-23.80M-37.15M-42.03M-40.56M-47.65M-48.50M-70.06M-50.61M-50.71M-49.66M-53.70M
Additional items
EPS (Basic)
-0.40-0.75-0.273.90-0.54-0.59-1.42-0.81-0.92-0.56-0.85-0.75-0.69-0.88-0.82-1.17-0.86-0.86-0.82-0.87
EPS (Diluted)
-0.40-0.75-0.273.77-0.54-0.57-1.42-0.81-0.92-0.56-0.85-0.75-0.69-0.89-0.82-1.17-0.85-0.85-0.81-0.87
Shares Outstanding
43.44M43.08M44.43M44.87M45.61M45.16M40.68M39.95M42.73M42.16M43.66M55.70M58.98M54.42M58.91M59.66M59.08M59.05M60.46M61.97M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
43.44M43.08M44.43M46.38M45.61M46.64M40.68M39.95M42.73M42.16M43.66M55.70M58.98M53.77M58.91M59.66M59.72M59.70M61.02M61.97M
EBITDA
-18.36M-34.34M-32.64M239.69M-29.76M-32.55M-62.68M-37.52M-45.16M-45.41M-42.91M-49.95M-48.78M-54.97M-54.92M-75.72M-55.52M-55.18M-53.62M-57.17M
Tax Rate
27.51

Cullinan Therapeutics Income Statement API

Pull Cullinan Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CGEM&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY